TherapeuticsMD, Inc. 4
4 · TherapeuticsMD, Inc. · Filed Mar 28, 2014
Insider Transaction Report
Form 4
SEGAL NICHOLAS
Director
Transactions
- Sale
Common Stock
2014-03-26$6.70/sh−30,000$200,913→ 215,485 total - Sale
Common Stock
2014-03-26$6.70/sh−185,298$1,240,959→ 225,809 total(indirect: By Fourth Generation Private Equity Partners)
Holdings
- 146,560(indirect: By LLC)
Common Stock
Footnotes (3)
- [F1]Fourth Generation Private Equity sold 1,600,000 shares of TherapeuticsMD, Inc. (the "Company") common stock. Mr. Segal owns 11.5811% interest, Partners ("FG"), of which Mr. Segal disclaims beneficial ownership of these securities held by FG except to the extent of his pecuniary interest therein.
- [F2]Represents Mr. Segal's pro rata portion of 1,949,805 shares of the Company's common stock held directly by FG. Mr. Segal disclaims beneficial ownership of securities held by FG except to the extent of his pecuniary interest therein.
- [F3]Represents Mr. Segal's aggregate direct and indirect pro rata portion of 1,600,000 shares of the Company's common stock held by Seavest Capital Ventures, LLC ("Seavest"). Mr. Segal directly holds a 4.995% interest in Seavest and indirectly holds a 4.165% interest in Seavest, through his ownership interest in FG, which owns a 35.964% interest in Seavest. Mr. Segal disclaims beneficial ownership of securities held by Seavest except to the extent of his pecuniary interest therein.